Lahoti Overseas Ltd vs Welcure Drugs Pharmaceuticals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Lahoti Overseas Ltd is ₹ 37 as of 23 Oct 15:30 . The P/E Ratio of Lahoti Overseas Ltd changed from 4.9 on March 2021 to 7.8 on March 2026 . This represents a CAGR of 8.06% over 6 yearsThe P/E Ratio of Welcure Drugs & Pharmaceuticals Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 years The Market Cap of Lahoti Overseas Ltd changed from ₹ 39.82 crore on March 2021 to ₹ 111.06 crore on March 2026 . This represents a CAGR of 18.64% over 6 yearsThe Market Cap of Welcure Drugs & Pharmaceuticals Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 6 years The revenue of Lahoti Overseas Ltd for the Jun '26 is ₹ 92.12 crore as compare to the Mar '26 revenue of ₹ 90.45 crore. This represent the growth of 1.85% The revenue of Welcure Drugs & Pharmaceuticals Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Lahoti Overseas Ltd for the Jun '26 is ₹ 4.49 crore as compare to the Mar '26 ebitda of ₹ 1.72 crore. This represent the growth of 161.05% The ebitda of Welcure Drugs & Pharmaceuticals Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Lahoti Overseas Ltd changed from ₹ 4.59 crore to ₹ 3.1 crore over 9 quarters. This represents a CAGR of -16.01% The net profit of Welcure Drugs & Pharmaceuticals Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The Dividend Payout of Lahoti Overseas Ltd changed from 14.55 % on March 2021 to 3.91 % on March 2026 . This represents a CAGR of -19.67% over 6 yearsThe Dividend Payout of Welcure Drugs & Pharmaceuticals Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Lahoti Overseas Ltd

Lahoti Overseas Limited was incorporated on 24 April, 1995 as a Private Limited Company and was converted into a Public Limited Company on 26 April, 1995.
The Company was promoted by Umesh Lahoti to take over the business of the Erstwhile Partnership Firm, Lahoti Exports (a merchant exporter).
Lahoti Exports was set up in 1990 to export cotton yarn.
The Erstwhile Partnership Firm was exporting cotton yarn to the Far East and Middle-East countries like Hong Kong, South Korea, Sri Lanka, UAE, etc. Presently, the Company is engaged in the business of Merchant Exports of Cotton textiles and to specialize in the export of quality Cotton Yarns and fabrics.
Apart from this, it is engaged in setting up of Power projects and to generate, supply, distribute, transmit and transform electric or other sources of power.

About Welcure Drugs & Pharmaceuticals Ltd

Incorporated on 4th June, 1992, Welcure Drugs And Pharmaceuticals Limited(WDPL) was promoted by D C Jain, Sanjeev Jain and Sandeep Jain.
The promoters have interests in other companies such as Paam Pharmaceuticals, Pioneer Products, Alirox Abrasives, A K Laboratories, etc. WDPL had come out with a Rs 4-cr public issue in Aug.'94 to part-finance the Rs 12 Crore project to manufacture bulk drugs in Rajasthan and finance investments in a subsidiary, A K Laboratories (AKL).
The company has also submitted the letter of offer for a Rs 7.09-cr rights issue of equity shares in Jan.'96 to finance its expansion programmes. Products of WDPL include bulk drugs such as ampicillin and trimethoprim, drugs intermediates and pharmaceutical formulations.
It has decided to add amoxycillin and cloxacillin to its range with provision to manufacture ibuprofen.

FAQs for the comparison of Lahoti Overseas Ltd and Welcure Drugs & Pharmaceuticals Ltd

Which company has a larger market capitalization, Lahoti Overseas Ltd or Welcure Drugs & Pharmaceuticals Ltd?

Market cap of Lahoti Overseas Ltd is 107 Cr while Market cap of Welcure Drugs & Pharmaceuticals Ltd is 22 Cr

What are the key factors driving the stock performance of Lahoti Overseas Ltd and Welcure Drugs & Pharmaceuticals Ltd?

The stock performance of Lahoti Overseas Ltd and Welcure Drugs & Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Lahoti Overseas Ltd and Welcure Drugs & Pharmaceuticals Ltd?

As of October 25, 2026, the Lahoti Overseas Ltd stock price is INR ₹37.0. On the other hand, Welcure Drugs & Pharmaceuticals Ltd stock price is INR ₹0.18.

How do dividend payouts of Lahoti Overseas Ltd and Welcure Drugs & Pharmaceuticals Ltd compare?

To compare the dividend payouts of Lahoti Overseas Ltd and Welcure Drugs & Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.